MDM2 inhibitors (Adamed Group)

N/A

Report date: 2025/01/26 16:31:36
NME

Base Information

Drug NameMDM2 inhibitors (Adamed Group)
Drug Alias NameADO-21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 degradersTumor protein p53 stimulantsp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2Tumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdamed
China Registration ClassN/A

Develop Information

Active CompaniesAdamed
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A